In February 2024 a putative class action complaint against Molecular Partners, its directors, and certain of its executive officers, originally filed in July 2022 in the U.S. District Court for the ...
As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.
The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...
Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...
University of Alberta researchers have developed a new molecular imaging test that could lead to improved diagnosis of lung ...
A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.
CStone Pharmaceuticals ('CStone', HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that the first patient ...
Small-cell lung cancer is a highly malignant form of lung cancer, also known as oat-cell carcinoma, that accounts for approximately 15% of lung cancer cases. Composed of small, ovoid cells with ...
The BIRAC funding will enable comprehensive toxicology assessments, a necessary step in preparing for IND submission with ...
In a recent trial, researchers found that Xpovio plus chemo had activity in NSCLC patients with KRAS mutations other than ...
The following is a summary of “Identification of Shared Pathways and Molecules Between Type 2 Diabetes and Lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback